New research offers promise of a simple injection that could be developed to limit the devastating consequences of heart attacks and strokes. Scientists have identified an enzyme, Mannan Binding Lectin-Associated Serine Protease-2 (MASP-2), that is found in blood and is a key component of the lectin pathway of complement activation, a component of the innate immune system.